Status:
UNKNOWN
Thromboembolic Events in Severe COVID-19 Patients
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Pulmonary Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary obj...
Eligibility Criteria
Inclusion
- Confirmed infection with the Sars-CoV-2 virus (RT-PCR)
- Hospitalization in Intensive Care Unit
- Age over 18 years Old
Exclusion
- Refusal of the patient to participate in data collection
Key Trial Info
Start Date :
April 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04405869
Start Date
April 29 2020
End Date
April 1 2021
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil
Strasbourg, France, 67091